CompletedPhase 2NCT00864227

Evaluating the Safety and Effectiveness of an Umbilical Cord Blood Stem Cell Transplant (BMT CTN 0604)

Studying Burkitt lymphoma

Last synced from ClinicalTrials.gov May 7, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: Medical College of Wisconsin
Principal Investigator: Mary Horowitz, MD, MS, MD
Center for International Blood and Marrow Transplant Research (CIBMTR), Medical College of Wisconsin
Intervention: Hematopoietic Umbilical Cord Blood Stem Cell Transplantation(biological)
Enrollment: 54 enrolled
Eligibility: 1-70 years · All sexes
Timeline: 2008 – 2013

Study locations (16)

City of Hope National Medical Center, Duarte, California, United States
University of Florida College of Medicine, Shands, Gainesville, Florida, United States
H. Lee Moffitt Cancer Center, Tampa, Florida, United States
University of Iowa Hospitals and Clinics, Iowa City, Iowa, United States
University of Kansas Hospital, Kansas City, Kansas, United States
Dana-Farber Cancer Institute (DFCI), Brigham & Women's Hospital, Boston, Massachusetts, United States
Dana-Farber Cancer Institute (DFCI), Massachusetts General Hospital, Boston, Massachusetts, United States
University of Minnesota, Minneapolis, Minnesota, United States
Washington University, Barnes Jewish Hospital, St Louis, Missouri, United States
Weill Cornell Medical College, NY Presbyterian Hospital, New York, New York, United States
Ohio State, Arthur G. James Cancer Hospital, Columbus, Ohio, United States
University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania, United States
Medical University of South Carolina, Charleston, South Carolina, United States
Texas Transplant Institute, San Antonio, Texas, United States
Virginia Commonwealth University, Medical College of Virginia (MCV) Hospital, Richmond, Virginia, United States
+1 more locations on ClinicalTrials.gov

Collaborators

National Heart, Lung, and Blood Institute (NHLBI) · Blood and Marrow Transplant Clinical Trials Network · National Cancer Institute (NCI) · National Marrow Donor Program

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00864227 on ClinicalTrials.gov

Other trials for Burkitt lymphoma

Additional recruiting or active studies for the same condition.

See all trials for Burkitt lymphoma →

← Back to all trials